Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Guardant Health, Inc. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$48.25 - $100.49 $3.02 Million - $6.28 Million	-62,500 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$98.77 - $132.17 $1.32 Million - $1.77 Million	13,400 Added 27.29%	62,500 $7.81 Million
Q2 2021 Aug 06, 2021	BUY	$109.77 - $165.68 $1.91 Million - $2.88 Million	17,400 Added 54.89%	49,100 $6.1 Million
Q1 2021 May 06, 2021	BUY	$127.04 - $179.1 $1.99 Million - $2.81 Million	15,700 Added 98.13%	31,700 $4.84 Million
Q4 2020 Feb 09, 2021	BUY	$99.96 - $135.93 $439,824 - $598,092	4,400 Added 37.93%	16,000 $2.06 Million
Q2 2020 Aug 06, 2020	SELL	$60.49 - $97.5 $235,911 - $380,250	-3,900 Reduced 25.16%	11,600 $941,000
Q1 2020 May 11, 2020	BUY	$59.04 - $88.81 $135,792 - $204,263	2,300 Added 17.42%	15,500 $1.08 Million
Q4 2019 Feb 05, 2020	BUY	$59.49 - $82.78 $785,268 - $1.09 Million	13,200 New	13,200 $1.03 Million

Others Institutions Holding GH

# of Institutions

324

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

Vanguard Group Inc Valley Forge, PA

11.7M
Shares

$552 Million
0.0% of portfolio
Black Rock Inc. New York, NY

11.2M
Shares

$531 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.1M
Shares

$478 Million
0.04% of portfolio
Cadian Capital Management, LP New York, NY

6.93M
Shares

$327 Million
8.13% of portfolio
Deep Track Capital, LP Greenwich, CT

6M
Shares

$283 Million
5.07% of portfolio

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.83B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account